BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES
- 5 January 1985
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 325 (8419), 16-19
- https://doi.org/10.1016/s0140-6736(85)90966-3
Abstract
No abstract availableFunding Information
- Ontario Mental Health Foundation
- National Institutes of Health (AGNS 03047)
- Medical Research Council Canada (PG21)
- Dagmar Marshalls Fond
- Kræftens Bekæmpelse
This publication has 10 references indexed in Scilit:
- Treatment of Advanced Breast Cancer with TamoxifenPublished by Springer Science and Business Media LLC ,1984
- Standardization of steroid receptor assays in human breast cancer—I. Reproducibility of estradiol and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1983
- Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.BMJ, 1983
- Antiestrogen treatment of postmenopausal women with primary high risk breast cancerBreast Cancer Research and Treatment, 1983
- Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year resultsBreast Cancer Research and Treatment, 1983
- Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patientsInternational Journal of Cancer, 1981
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPYThe Lancet, 1981
- Oestrogen-receptor status and sites of metastasis in breast cancerBritish Journal of Cancer, 1981
- ŒSTROGEN RECEPTORS AND PROGNOSIS IN EARLY BREAST CANCERThe Lancet, 1979
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957